Ovid Therapeutics (OVID) EBIT Margin (2020 - 2026)
Ovid Therapeutics (OVID) reported EBIT Margin of -2141.61% for Q2 2026, down 2060.73 percentage points from -80.88% a year earlier.
Powered by 
Analysis
Ovid Therapeutics (OVID) EBIT Margin (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ovid Therapeutics' EBIT Margin came in at -3686.67%, down 3061.64 percentage points year-over-year; for FY2025, it was -585.20%, up 10348.54 percentage points from FY2024.
- EBIT Margin has a five-year change of +60.19 percentage points (FY2020 to FY2025).
- By year, EBIT Margin came in at -10933.75% in FY2024 (+4188.96 pp), -15122.70% in FY2023 (-11426.27 pp), -3696.44% in FY2022 (-3756.05 pp) and 59.61% in FY2021 (+705.00 pp).
- Five-year quarterly EBIT Margin spans a low of -115329.27% in Q3 2022 and a high of -80.88% in Q2 2025.
- Year over year, EBIT Margin gained in four of the last seven quarters, with an average year-over-year change of +3536.86 percentage points.
- The high point for year-over-year EBIT Margin in five years was Q3 2023 (a gain of 104293.49 percentage points); the low point was Q1 2023 (a drop of 21438.17 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | Ovid Therapeutics | 469.28 Mn | 101.30 Mn | - | -2,141.61% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,141.61% |
| Dec 31, 2025 | -1,712.12% |
| Sep 30, 2025 | -9,487.12% |
| Jun 30, 2025 | -80.88% |
| Mar 31, 2025 | -9,653.85% |
| Dec 31, 2024 | -14,107.89% |
| Sep 30, 2024 | -7,645.09% |
| Jun 30, 2024 | -12,140.24% |
| Mar 31, 2024 | -11,768.24% |
| Dec 31, 2023 | -12,808.45% |
| Sep 30, 2023 | -11,035.78% |
| Jun 30, 2023 | -18,896.00% |
| Mar 31, 2023 | -22,563.64% |
| Dec 31, 2022 | -26,302.75% |
| Sep 30, 2022 | -115,329.27% |
| Mar 31, 2022 | -1,125.47% |
| Mar 31, 2021 | 84.73% |
| Dec 31, 2020 | -378.58% |
| Sep 30, 2020 | -237.25% |
API Access
Ovid Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();